Executive Profile*

David G. Nance

AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 1 different industries.

See Board Relationships
64--

Background*

David G. Nance served as the Chief Executive Officer and President of Introgen Therapeutics Inc. from its inception in June 1993 to November 2008. From 1992 to 1996, Mr. Nance served as Managing Partner of Texas Biomedical Development Partners, the investment group that founded Introgen Therapeutics Inc. He served as the Chairman of Introgen Therapeutics Inc. from June 5, 2007 to March 11, 2009. Mr. Nance serves as a Director of Gendux Pharmaceuticals Ltd. He also serves ...

Read Full Background

Corporate Headquarters*

8066 El Rio
Houston, Texas 77054

United States

Phone: 713-842-1017
Fax: 713-842-6660

Board Members Memberships*

Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.